The expression level of GFAP in the ADT group (Figure 7B, DG: F(1,62) = 36.518, P < 0.001; CA2-3: F(1,62) = 9.187, P = 0.004; CA1: F(1,62) = 47.650, P < 0.001) was significantly lower than that of the AD group. Here, GFAP is linked to Alzheimer disease.